The risk and prophylactic management of bladder cancer after various forms of radiotherapy

Samir P. Shirodkar, T. A. Kishore, Mark S. Soloway

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Prostate cancer is the most common cancer diagnosed in men and remains the second most lethal malignancy. Most patients undergoing treatment elect for radical prostatectomy or radiation. As the number of patients treated has increased and survival improved, delayed complications of these modalities has assumed increased importance. Recent studies report an increased risk of certain cancers after radiation for prostate cancer. This review aims to summarize recent data. RECENT FINDINGS: Recent studies have confirmed the association of prostate radiation with secondary cancers. The most common secondary malignancy is bladder carcinoma. We have treated 44 patients with bladder cancer who had radiation therapy for prostate cancer. At diagnosis, 60% had tumor, which invaded the bladder muscle (T2 or greater disease). The mean latency from radiation to diagnosis of bladder cancer was 5.5 years. SUMMARY: Radiation therapy for prostate cancer is associated with an increased risk of bladder cancer. In our series, patients presented at higher stage than expected from population-based studies of bladder cancer. Patients and their physicians should be aware of such risks when choosing therapy for prostate cancer. Hematuria following radiation therapy for prostate cancer should be investigated rather than being attributed to radiation-induced cystitis.

Original languageEnglish
Pages (from-to)500-503
Number of pages4
JournalCurrent Opinion in Urology
Volume19
Issue number5
DOIs
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

Risk Management
Urinary Bladder Neoplasms
Prostatic Neoplasms
Radiotherapy
Radiation
Neoplasms
Urinary Bladder
Cystitis
Hematuria
Prostatectomy
Prostate
Carcinoma
Physicians
Muscles
Survival
Therapeutics
Population

Keywords

  • Bladder cancer
  • Prostate cancer
  • Secondary malignancy after radiation

ASJC Scopus subject areas

  • Urology

Cite this

The risk and prophylactic management of bladder cancer after various forms of radiotherapy. / Shirodkar, Samir P.; Kishore, T. A.; Soloway, Mark S.

In: Current Opinion in Urology, Vol. 19, No. 5, 01.09.2009, p. 500-503.

Research output: Contribution to journalArticle

Shirodkar, Samir P. ; Kishore, T. A. ; Soloway, Mark S. / The risk and prophylactic management of bladder cancer after various forms of radiotherapy. In: Current Opinion in Urology. 2009 ; Vol. 19, No. 5. pp. 500-503.
@article{3c13b82579cf4c6db36ac73f2ed2eae9,
title = "The risk and prophylactic management of bladder cancer after various forms of radiotherapy",
abstract = "Lippincott Williams & Wilkins.",
keywords = "Bladder cancer, Prostate cancer, Secondary malignancy after radiation",
author = "Shirodkar, {Samir P.} and Kishore, {T. A.} and Soloway, {Mark S.}",
year = "2009",
month = "9",
day = "1",
doi = "10.1097/MOU.0b013e32832eb3b3",
language = "English",
volume = "19",
pages = "500--503",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The risk and prophylactic management of bladder cancer after various forms of radiotherapy

AU - Shirodkar, Samir P.

AU - Kishore, T. A.

AU - Soloway, Mark S.

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Lippincott Williams & Wilkins.

AB - Lippincott Williams & Wilkins.

KW - Bladder cancer

KW - Prostate cancer

KW - Secondary malignancy after radiation

UR - http://www.scopus.com/inward/record.url?scp=68949186462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949186462&partnerID=8YFLogxK

U2 - 10.1097/MOU.0b013e32832eb3b3

DO - 10.1097/MOU.0b013e32832eb3b3

M3 - Article

C2 - 19553822

AN - SCOPUS:68949186462

VL - 19

SP - 500

EP - 503

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 5

ER -